AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
Merck registers Phase 3 sotatercept HFpEF trial; Terns completes two TERN-701 Phase 1 studiesSep 24Weekly roundup, 3 itemsMerck & Co., Inc.sotatercept-csrk
Amneal's itraconazole ANDA gets labeling supplement approved by FDASep 14Regulatory decisionAmneal Pharmaceuticals, LLCitraconazole
Novartis-linked melanoma trial posts results; new ITP preference survey and LASIK study activeAug 27Weekly roundup, 4 itemsdabrafenibitraconazole
Hutchmed completes Phase 1 drug interaction study for HMPL-453 tartrate tabletsJul 13Trial updateHutchmed
AstraZeneca posts NATRON Phase III benralizumab results; registers ROSY-S anifrolumab rollover studyJul 10Weekly roundup, 9 itemsanifrolumab-fniaAstraZeneca
Janssen keeps Sporanox label approvals; J&J tapped as collaborator on new V-Wave heart failure trialJul 10Weekly roundup, 3 itemsitraconazoleJohnson & Johnson